LYG2 Human Pre-designed siRNA Set A contains three designed siRNAs for LYG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYL1 Human Pre-designed siRNA Set A contains three designed siRNAs for LYL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYN Human Pre-designed siRNA Set A contains three designed siRNAs for LYN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYNX1 Human Pre-designed siRNA Set A contains three designed siRNAs for LYNX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYPD1 Human Pre-designed siRNA Set A contains three designed siRNAs for LYPD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYPD2 Human Pre-designed siRNA Set A contains three designed siRNAs for LYPD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYPD3 Human Pre-designed siRNA Set A contains three designed siRNAs for LYPD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYPD6 Human Pre-designed siRNA Set A contains three designed siRNAs for LYPD6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYPD6B Human Pre-designed siRNA Set A contains three designed siRNAs for LYPD6B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYPD8 Human Pre-designed siRNA Set A contains three designed siRNAs for LYPD8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYPLA1 Human Pre-designed siRNA Set A contains three designed siRNAs for LYPLA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYPLA2 Human Pre-designed siRNA Set A contains three designed siRNAs for LYPLA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYPLAL1 Human Pre-designed siRNA Set A contains three designed siRNAs for LYPLAL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYRM4 Human Pre-designed siRNA Set A contains three designed siRNAs for LYRM4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYRM7 Human Pre-designed siRNA Set A contains three designed siRNAs for LYRM7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lys(CO-C3-p-I-Ph)-O-tBu is a pharmacokinetic modifier (PK modifier) that can improve the PK properties of PSMA ligand molecules. Lys(CO-C3-p-I-Ph)-O-tBu can increase the residence time of PSMA ligand in plasma by increasing its binding capacity to albumin. Lys(CO-C3-p-I-Ph)-O-tBu also reduces salivary gland absorption, possibly extending the half-life of the active compound. Ac-PSMA-trillium is a suitable PSMA-targeting compound […]

Lys(CO-C3-p-I-Ph)-O-tBu is a pharmacokinetic modifier (PK modifier) that can improve the PK properties of PSMA ligand molecules. Lys(CO-C3-p-I-Ph)-O-tBu can increase the residence time of PSMA ligand in plasma by increasing its binding capacity to albumin. Lys(CO-C3-p-I-Ph)-O-tBu also reduces salivary gland absorption, possibly extending the half-life of the active compound. Ac-PSMA-trillium is a suitable PSMA-targeting compound […]

Lys(CO-C3-p-I-Ph)-O-tBu is a pharmacokinetic modifier (PK modifier) that can improve the PK properties of PSMA ligand molecules. Lys(CO-C3-p-I-Ph)-O-tBu can increase the residence time of PSMA ligand in plasma by increasing its binding capacity to albumin. Lys(CO-C3-p-I-Ph)-O-tBu also reduces salivary gland absorption, possibly extending the half-life of the active compound. Ac-PSMA-trillium is a suitable PSMA-targeting compound […]

Lys(CO-C3-p-I-Ph)-O-tBu is a pharmacokinetic modifier (PK modifier) that can improve the PK properties of PSMA ligand molecules. Lys(CO-C3-p-I-Ph)-O-tBu can increase the residence time of PSMA ligand in plasma by increasing its binding capacity to albumin. Lys(CO-C3-p-I-Ph)-O-tBu also reduces salivary gland absorption, possibly extending the half-life of the active compound. Ac-PSMA-trillium is a suitable PSMA-targeting compound […]

Lys(CO-C3-p-I-Ph)-O-tBu is a pharmacokinetic modifier (PK modifier) that can improve the PK properties of PSMA ligand molecules. Lys(CO-C3-p-I-Ph)-O-tBu can increase the residence time of PSMA ligand in plasma by increasing its binding capacity to albumin. Lys(CO-C3-p-I-Ph)-O-tBu also reduces salivary gland absorption, possibly extending the half-life of the active compound. Ac-PSMA-trillium is a suitable PSMA-targeting compound […]

Lys(CO-C3-p-I-Ph)-OMe is a pharmacokinetic modifier (PK modifier) that can improve the PK properties of PSMA ligand molecules (such as Ac-PSMA-trillium). Lys(CO-C3-p-I-Ph)-OMe can increase the residence time of Ac-PSMA-trillium in plasma by increasing its binding capacity to albumin. Lys(CO-C3-p-I-Ph)-OMe also reduces salivary gland absorption of Ac-PSMA-trillium, potentially extending its half-life. Ac-PSMA-trillium is a suitable PSMA-targeting compound […]

Lys(CO-C3-p-I-Ph)-OMe is a pharmacokinetic modifier (PK modifier) that can improve the PK properties of PSMA ligand molecules (such as Ac-PSMA-trillium). Lys(CO-C3-p-I-Ph)-OMe can increase the residence time of Ac-PSMA-trillium in plasma by increasing its binding capacity to albumin. Lys(CO-C3-p-I-Ph)-OMe also reduces salivary gland absorption of Ac-PSMA-trillium, potentially extending its half-life. Ac-PSMA-trillium is a suitable PSMA-targeting compound […]

Lys(CO-C3-p-I-Ph)-OMe is a pharmacokinetic modifier (PK modifier) that can improve the PK properties of PSMA ligand molecules (such as Ac-PSMA-trillium). Lys(CO-C3-p-I-Ph)-OMe can increase the residence time of Ac-PSMA-trillium in plasma by increasing its binding capacity to albumin. Lys(CO-C3-p-I-Ph)-OMe also reduces salivary gland absorption of Ac-PSMA-trillium, potentially extending its half-life. Ac-PSMA-trillium is a suitable PSMA-targeting compound […]

Lys(CO-C3-p-I-Ph)-OMe is a pharmacokinetic modifier (PK modifier) that can improve the PK properties of PSMA ligand molecules (such as Ac-PSMA-trillium). Lys(CO-C3-p-I-Ph)-OMe can increase the residence time of Ac-PSMA-trillium in plasma by increasing its binding capacity to albumin. Lys(CO-C3-p-I-Ph)-OMe also reduces salivary gland absorption of Ac-PSMA-trillium, potentially extending its half-life. Ac-PSMA-trillium is a suitable PSMA-targeting compound […]

Lys(CO-C3-p-I-Ph)-OMe is a pharmacokinetic modifier (PK modifier) that can improve the PK properties of PSMA ligand molecules (such as Ac-PSMA-trillium). Lys(CO-C3-p-I-Ph)-OMe can increase the residence time of Ac-PSMA-trillium in plasma by increasing its binding capacity to albumin. Lys(CO-C3-p-I-Ph)-OMe also reduces salivary gland absorption of Ac-PSMA-trillium, potentially extending its half-life. Ac-PSMA-trillium is a suitable PSMA-targeting compound […]

LYSMD2 Human Pre-designed siRNA Set A contains three designed siRNAs for LYSMD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYSMD3 Human Pre-designed siRNA Set A contains three designed siRNAs for LYSMD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lyso Flipper-TR 29 is a Flipper probe that can label lysosomes. Lyso Flipper-TR 29 enters lysosomes and late endosomes by transient deprotonation to cross their membranes in neutral form[1].

LysoSR-549 is a multifunctional dye. Dyes are important tools in biological experiments. They can help researchers observe and analyze cell structures, track biomolecules, evaluate cell functions, distinguish cell types, detect biomolecules, study tissue pathology and monitor microorganisms. Their applications range from basic scientific research to clinical A wide range of diagnostics. Dyes are also widely […]

LYST Human Pre-designed siRNA Set A contains three designed siRNAs for LYST gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYVE1 Human Pre-designed siRNA Set A contains three designed siRNAs for LYVE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LYZ Human Pre-designed siRNA Set A contains three designed siRNAs for LYZ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LZ-1105 is a multifunctional dye. Dyes are important tools in biological experiments. They can help researchers observe and analyze cell structures, track biomolecules, evaluate cell functions, distinguish cell types, detect biomolecules, study tissue pathology and monitor microorganisms. Their applications range from basic scientific research to clinical A wide range of diagnostics. Dyes are also widely […]

LZIC Human Pre-designed siRNA Set A contains three designed siRNAs for LZIC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LZTFL1 Human Pre-designed siRNA Set A contains three designed siRNAs for LZTFL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LZTR1 Human Pre-designed siRNA Set A contains three designed siRNAs for LZTR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LZTS1 Human Pre-designed siRNA Set A contains three designed siRNAs for LZTS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LZTS2 Human Pre-designed siRNA Set A contains three designed siRNAs for LZTS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

m-Cresol purple is a pH indicator dye with large cross section and halochromic property in neutral pH range[1].

m-Cresol purple sodium (Metacresol purple sodium) is a pH indicator. m-Cresol purple sodium solution from yellow to blue in the pH range from 7.5 to 9.0[1].

m-Nifedipine (Standard) is the analytical standard of m-Nifedipine. This product is intended for research and analytical applications. m-Nifedipine is an impurity of Nifedipine (BAY-a-1040). Nifedipine is a potent calcium channel blocker and agent of choice for cardiac insufficiencies[1].

m-Nisoldipine (KR-1008) is a dihydropyridine calcium antagonist that can significantly increase cardiac output and heart index, significantly reduce the negative inotropic effect on the myocardium, and has a relatively high selectivity for the thoracic aorta. m-Nisoldipine can be used in the research of cardiovascular diseases[1].